GSP Crop Science IPO Deep Dive | Worth Your Money? | Management Answers All

Amid heightened volatility in global markets due to the ongoing West Asia crisis, the IPO landscape is also feeling the pressure. While some big listings have been deferred, GSP Crop Science has gone ahead with its ₹400 crore public issue, signaling confidence in its business fundamentals. In this special episode, we speak with Bhavesh Shah, Chairman & MD, and Shail Shah, CFO, to understand the company’s growth strategy, strong R&D capabilities, and global expansion plans. The management also discusses key IPO details, debt reduction plans, and financial outlook. With operations across multiple countries and a focus on agrochemical innovation, is this IPO worth your attention? Tune in as we decode the opportunity, risks, and long-term potential of GSP Crop Science.